In8bio Inc Financial Flexibility Index

Latest as of June 2026: -1.04x

In8bio Inc financial flexibility index. In8bio Inc (INAB) has a Financial Flexibility Index of -1.04x as of June 2026. Free cash flow of $-3.51 Million (operating CF $-3.75 Million minus capex $233.00K) represents -1% of total liabilities ($3.38 Million).

Financial Flexibility Index

-1.04x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-3.51 Million
Operating CF − Capex

Total Liabilities

$3.38 Million
USD

Capital Expenditures

$233.00K
USD

Financial Flexibility Index of In8bio Inc (2018–2025)

Financial flexibility index of In8bio Inc from 2018 to 2025. Historical Financial Flexibility Index trend for In8bio Inc across 8 annual periods. Explore In8bio Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

In8bio Inc Financial Flexibility Index by Year (2018–2025)

In8bio Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for In8bio Inc. For the full cash flow conversion analysis, see In8bio Inc cash conversion from operations.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -2.69x $-12.71 Million $-12.71 Million $4.72 Million ▲ +27.6%
2024 -3.72x $-24.05 Million $-24.15 Million $6.47 Million ▼ -43.4%
2023 -2.59x $-22.74 Million $-23.34 Million $8.77 Million ▼ -30.9%
2022 -1.98x $-20.42 Million $-24.12 Million $10.31 Million ▲ +39.4%
2021 -3.27x $-13.20 Million $-13.51 Million $4.04 Million ▼ -24.0%
2020 -2.64x $-6.82 Million $-7.13 Million $2.59 Million ▲ +13.0%
2019 -3.03x $-4.47 Million $-4.80 Million $1.48 Million ▼ -87.9%
2018 -1.61x $-2.01 Million $-2.77 Million $1.25 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities